| scholarly article | Q13442814 |
| P50 | author | Mohammad Arjomandzadegan | Q61090443 |
| Manijeh Kahbazi | Q89427903 | ||
| Taha Fereydouni | Q89427907 | ||
| P2093 | author name string | Marzieh Ebrahimi | |
| Fatemeh Karimi | |||
| Amir Reza Najmi | |||
| Nader Zarinfar | |||
| P2860 | cites work | Probiotics for the prevention of pediatric antibiotic-associated diarrhea | Q24235039 |
| Probiotics for treating acute infectious diarrhoea | Q24236704 | ||
| Probiotics for treating infectious diarrhoea | Q24247695 | ||
| Gastroenteritis Therapies in Developed Countries: Systematic Review and Meta-Analysis | Q28088494 | ||
| Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial | Q28142345 | ||
| Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents | Q28300892 | ||
| Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics | Q33439062 | ||
| Microbes in gastrointestinal health and disease | Q33943525 | ||
| A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children | Q33988931 | ||
| Does taking probiotics routinely with antibiotics prevent antibiotic associated diarrhoea? | Q34030781 | ||
| Nitazoxanide for the empiric treatment of pediatric infectious diarrhea | Q34251544 | ||
| Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. | Q34409280 | ||
| Probiotics in the Treatment and Prevention of Acute Infectious Diarrhea in Infants and Children: A Systematic Review of Published Randomized, Double-Blind, Placebo-Controlled Trials | Q34431156 | ||
| Shigellosis | Q34557460 | ||
| Clinical and microbiological profiles of shigellosis in children | Q35627497 | ||
| WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator | Q53665491 | ||
| Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. | Q54611248 | ||
| Lactobacillus reuteri Strain Combination In Helicobacter pylori Infection | Q62803733 | ||
| Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019) | Q73540460 | ||
| Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to enteropathogenic Escherichia coli infection | Q78293150 | ||
| The delivery of probiotics and prebiotics to infants | Q81243746 | ||
| Decreasing Shigellosis-related Deaths withoutShigellaspp.–specific Interventions, Asia | Q35804868 | ||
| Probiotics and prebiotics in gastrointestinal disorders. | Q36036491 | ||
| Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review | Q36237066 | ||
| Probiotics: facts and myths | Q36322211 | ||
| Probiotics in primary care pediatrics | Q36557591 | ||
| Clinical efficacy of probiotics: review of the evidence with focus on children | Q36620391 | ||
| Probiotics: sorting the evidence from the myths | Q37099047 | ||
| Acute infectious diarrhea in children | Q37332138 | ||
| Clinical use of probiotics in the pediatric population | Q37401597 | ||
| Probiotics for prevention of nosocomial infections: efficacy and adverse effects | Q37928883 | ||
| Sharing Shigella: risk factors for a multicommunity outbreak of shigellosis | Q38483700 | ||
| Factors associated with seeking medical care and submitting a stool sample in estimating the burden of foodborne illness. | Q40460960 | ||
| Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial | Q40588111 | ||
| Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. | Q40926741 | ||
| The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children | Q41535151 | ||
| Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children | Q42226591 | ||
| Probiotics have clinical, microbiologic, and immunologic efficacy in acute infectious diarrhea | Q44365789 | ||
| Perinatal outcome following third-trimester exposure to paroxetine: an alternative interpretation | Q44471456 | ||
| Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake | Q45008188 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | placebo | Q269829 |
| bacillary dysentery | Q3778137 | ||
| P304 | page(s) | 3194010 | |
| P577 | publication date | 2016-11-30 | |
| P1433 | published in | Advances in medicine | Q27726301 |
| P1476 | title | Efficacy of Synbiotics for Treatment of Bacillary Dysentery in Children: A Double-Blind, Randomized, Placebo-Controlled Study | |
| P478 | volume | 2016 |
Search more.